Lepu Biopharma Co., Ltd.
Industry Group: Pharmaceuticals
Country/Region: China
Identifier: HKG:2157
Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 714 out of 909
Universe
Global Universe 13233 out of 16009
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Daewoong Co., Ltd. |
28.4
Medium
|
445 out of 909 |
Lepu Biopharma Co., Ltd. |
34.1
High
|
714 out of 909 |
KYORIN Pharmaceutical Co., Ltd. |
34.5
High
|
742 out of 909 |
Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS |
36.6
High
|
821 out of 909 |
IGM Biosciences, Inc. |
39
High
|
867 out of 909 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Lepu Biopharma Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Lepu Biopharma Co., Ltd.'s Management of ESG Material Risk is Average